Junshi Biosciences Announces Phase 3 Study of Toripalimab Combined with Bevacizumab for the First-line Treatment of Advanced Hepatocellular Carcinoma Meets Primary Endpoint
Globe Newswire12-06-2024, 09:06
Fraser Institute News Release: More than 94% of global population experienced decline in freedom from 2019 to 2020 26-01-2023, 17:00